Ann: Quarterly Review, page-2

Jenbrook • EVE entered a binding Share Purchase Deed to acquire 100% of leading organic tea tree oil producer Jenbrook Pty Ltd, one of Australia’s largest organic tea tree oil producers supplying both local and international markets with high quality tea tree oil and hydrosol • Acquisition includes plantation assets and a 49% holding in rapidly growing US distribution business Naturally Australian Products LLC, a prominent natural oils distributor in the USA • Strong revenue generating, Jenbrook reported revenues of $2.1 million for FY17 from its tea tree products, with a further unaudited contribution of US$1.5 million from its subsidiary NAP Meluka Health • Meluka Health signed a binding conditional Term Sheet with The Hydroponics Company Limited (ASX: THC) and Jenbrook Pty Ltd to grow cannabis on a portion of Jenbrook’s Robyndale tea tree plantation in Northern New South Wales • Lease with The Hydroponics Company Limited (THC) and Jenbrook Pty Ltd finalised in July to grow cannabis on a portion of Jenbrook’s Robyndale tea tree plantation Omni Innovation • Omni Innovation’s distribution partner, Eagle Health will continue to roll out diabetes experience and education stores throughout 2018 and 2019 • Based on continuing strong customer support and ongoing refinement of the business model, Eagle Health aims to open 100 stores across China